Literature DB >> 1703323

A potent nonpeptide antagonist of the substance P (NK1) receptor.

R M Snider1, J W Constantine, J A Lowe, K P Longo, W S Lebel, H A Woody, S E Drozda, M C Desai, F J Vinick, R W Spencer.   

Abstract

CP-96,345 [(2S, 3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)- methyl]-1-azabicyclo[2.2.2]octan-3-amine] is a potent nonpeptide antagonist of the substance P (NK1) receptor. CP-96,345 inhibited 3H-labeled substance P binding and was a classical competitive antagonist in the NK1 monoreceptor dog carotid artery preparation. CP-96,345 inhibited substance P-induced salivation in the rat, a classical in vivo bioassay, but did not inhibit NK2, NK3, or numerous other receptors; it is thus a selective NK1 antagonist. This compound may prove to be a powerful tool for investigation of the physiological properties of substance P and exploration of its role in diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703323     DOI: 10.1126/science.1703323

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  125 in total

Review 1.  Molecular approaches to contraceptive development.

Authors:  U Natraj
Journal:  J Biosci       Date:  2001-11       Impact factor: 1.826

2.  Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Authors:  J P Lai; W Z Ho; G X Zhan; Y Yi; R G Collman; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation.

Authors:  F Lembeck; J Donnerer; M Tsuchiya; A Nagahisa
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 4.  Role of substance P in inflammatory arthritis.

Authors:  N E Garrett; P I Mapp; S C Cruwys; B L Kidd; D R Blake
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

5.  Sensory nerve-mediated relaxation of guinea-pig isolated pulmonary artery: prejunctional modulation by alpha 2-adrenoceptor agonists but not sumatriptan.

Authors:  A Butler; S P Worton; C T O'Shaughnessy; H E Connor
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

6.  Effects of interactions of naturally-occurring neuropeptides on blood flow in the rat knee joint.

Authors:  F Y Lam; W R Ferrell
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

7.  A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically.

Authors:  S M Moussaoui; F Montier; A Carruette; J C Blanchard; P M Laduron; C Garret
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists.

Authors:  J C Beaujouan; E Heuillet; F Petitet; M Saffroy; Y Torrens; J Glowinski
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

9.  Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.

Authors:  U Gether; Y Yokota; X Emonds-Alt; J C Brelière; J A Lowe; R M Snider; S Nakanishi; T W Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

10.  Tachykinin NK1 and NK2 receptor antagonists and atropine-resistant ascending excitatory reflex to the circular muscle of the guinea-pig ileum.

Authors:  C A Maggi; R Patacchini; L Bartho; P Holzer; P Santicioli
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.